FPFS
VKTX icon

First Personal Financial Services’s Viking Therapeutics VKTX Stock Holding History

First Personal Financial Services’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-200
Closed -$2K – 749
2019
Q2 		$2K Hold
200
– – ﹤0.01% 673
2019
Q1 		$2K Hold
200
– – ﹤0.01% 660
2018
Q4 		$2K Buy
+200
New +$2.39K ﹤0.01% 630

Other funds holding VKTX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

First Personal Financial Services's VKTX Position: Q3 2019 in Review

First Personal Financial Services sold out of Viking Therapeutics (VKTX) in Q3 2019, closing a stake of 200 shares — an estimated $2K sold.

First Personal Financial Services first reported a position in VKTX in Q4 2018 and held it in 3 quarters. The position peaked at $2K in Q2 2019. 144 funds tracked by Wall St. Rank hold VKTX as of Q3 2019.

  • First Personal Financial Services reported no remaining Viking Therapeutics position as of Q3 2019 after selling out during the quarter.
  • First Personal Financial Services sold 200 Viking Therapeutics shares in Q3 2019, an estimated $2K.
  • First Personal Financial Services first reported a position in Viking Therapeutics in Q4 2018 and held it in 3 quarters.
  • First Personal Financial Services's Viking Therapeutics position peaked at $2K in Q2 2019.
  • 144 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2019.

Based on First Personal Financial Services's 13F filing for Q3 2019, filed 15 Oct 2019.